Repligen | 应收帐款人

金融业

USD

USD 2.95B

现金及等价物

USD 566.02M

USD 94.08M

USD 1.14B

USD 135.83M

USD 542.21M

USD 19.97M

USD 39.54M

1.78K

EPS每股收益

USD 0.49

股本和储备

USD 2.11B

USD 103.83M

债务利息支出

USD 5.5M

USD 7.31M

USD 542.21M

USD 7.18B

USD 13.29M

USD 177.95M

USD 19.97M

普通股股本

USD 56.33M

USD 164.06

USD 17.11M

USD 197.91M

销售和管理费用

USD 74.36M

USD 170.46M

贸易债权人

USD 30.01M

应收帐款人

USD 158.59M

	应收帐款人	更改		日
Agilent	USD 1.52B		34M	2025-12
Align Technology	USD 1.1B		2.38M	2025-12
Bio Techne	USD 184.61M		717K	2025-12
BioMarin Pharmaceutical	USD 908.21M		117.95M	2025-12
Bristol-Myers Squibb	USD 14.62B		485M	2025-09
Bruker	USD 544.9M		6M	2025-12
Charles River Laboratories	USD 1.43B		54.59M	2025-12
Danaher	USD 3.91B		762M	2025-12
Dentsply International	USD 688M		34M	2025-12
Exact Sciences	USD 306.05M		47.28M	2025-09
General Electric Aerospace	USD 15.28B		1.5B	2025-12
Henry Schein	USD 1.65B		92M	2025-12
Illumina	USD 854M		125M	2025-12
IQVIA Holdings	USD 3.43B		113M	2025-12
Mettler Toledo International	USD 778.24M		90.98M	2025-12
Myriad Genetics	USD 118M		19M	2025-09
OraSure Technologies	USD 38.1M		4.06M	2024-06
Pacific Biosciences Of California	USD 29.38M		3.05M	2024-09
Pfizer	USD 18.12B		2.02B	2025-09
Repligen	USD 158.59M		9.62M	2025-12
Revvity	USD 744.67M		64.41M	2025-12
Standard Biotools	USD 13.54M		1.07M	2025-09
Thermo Fisher Scientific	USD 8.9B		11M	2025-12
Waters	USD 828.84M		80.32M	2025-12
West Pharmaceutical Services	USD 574.4M		50.6M	2025-12

Repligen 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.